0001209191-17-053206.txt : 20170918
0001209191-17-053206.hdr.sgml : 20170918
20170918174646
ACCESSION NUMBER: 0001209191-17-053206
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170915
FILED AS OF DATE: 20170918
DATE AS OF CHANGE: 20170918
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Haqq Christopher
CENTRAL INDEX KEY: 0001612095
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36548
FILM NUMBER: 171090608
MAIL ADDRESS:
STREET 1: C/O ATARA BIOTHERAPEUTICS, INC.
STREET 2: 3260 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atara Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001604464
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 460920988
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BLVD
STREET 2: SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-278-8930
MAIL ADDRESS:
STREET 1: 611 GATEWAY BLVD
STREET 2: SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-09-15
0
0001604464
Atara Biotherapeutics, Inc.
ATRA
0001612095
Haqq Christopher
611 GATEWAY BOULEVARD
SUITE 900
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
EVP, R&D & Chief Scientific Of
Common Stock
2017-09-15
4
S
0
6000
15.30
D
349305
D
Common Stock
17312
I
See footnote
Common Stock
2688
I
See footnote
Transaction pursuant to Rule 10b5-1 Plan adopted September 27, 2016.
The shares are held by the Chris Haqq 2014 GRAT, of which the Reporting Person is trustee.
The shares are held by The Havenside Trust, of which the Reporting Person is trustee.
/s/ Tina Gullotta, Attorney-in-Fact for Christopher Haqq
2017-09-18